Discover how lipid nanoparticles (LNPs) are powering a new era of personalized nanomedicine. Nanoparticle delivery systems are making bedside RNA therapies a reality. A paradigm shift: from mass production to personalized RNA therapies Imagine a future where life-saving RNA therapies are not manufactured [...]
The journey from scientific discovery to patient benefit is often long and uncertain. But in recent years, lipid nanoparticles (LNPs) have emerged as a key enabler for accelerating the clinical translation of innovative therapies, including mRNA, proteins, peptides, and gene-editing tools. At DIVERSA, we are designing next-generation nanoparticles that [...]
2024 has been a transformative year for nanomedicine, with remarkable advancements showcasing the potential of nanoscale technologies to revolutionize healthcare
2024 has been a transformative year for nanomedicine, with remarkable advancements showcasing the potential of nanoscale technologies to revolutionize healthcare
Explore the importance of material selection in nanotechnology for biomedicine, focusing on biocompatibility, regulatory compliance, and DIVERSA Technologies’ customized nanoparticle solutions. The Importance of Material Selection in Nanotechnology for Biomedicine Nanotechnology holds immense promise in biomedicine, from targeted drug delivery to diagnostic imaging. However, [...]
Gene therapy and gene editing are revolutionizing the treatment landscape for genetic disorders, cancers, and other diseases. By directly modifying the genetic material within a patient’s cells, these advanced techniques offer the potential to correct underlying genetic defects, introduce new genes to fight disease, or [...]
Rare diseases collectively affect approximately 400 million patients worldwide [1]. Nevertheless, this number is expected to increase thanks to the rapid evolution of sequencing technologies that have identified more than 6,000 to 10,000 rare diseases [2]. However, most rare diseases still lack specific treatments, [...]
